<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 02 Jun 2021 20:08:08 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>第五批集采冲击超800亿市场！齐鲁、科伦、倍特……领跑，21款超10亿注射剂厮杀在即</title><link>https://mp.weixin.qq.com/s/CdQbupa0I0TFfVVUl4Ys_w</link><description></description><content:encoded><![CDATA[第五批集采冲击超800亿市场！齐鲁、科伦、倍特……领跑，21款超10亿注射剂厮杀在即]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:02:14 +0800</pubDate></item><item><title>【瞩目】齐鲁大爆发！15亿抗感染注射剂第3家过评</title><link>https://mp.weixin.qq.com/s/5Cq9jHDjfGCQUSddywb0RA</link><description></description><content:encoded><![CDATA[【瞩目】齐鲁大爆发！15亿抗感染注射剂第3家过评]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:02:14 +0800</pubDate></item><item><title>【获批】豪森拿下3亿抗肿瘤药！科伦等5家药企紧跟而至</title><link>https://mp.weixin.qq.com/s/WwBMSG8HZd0d0ncEVaB-sw</link><description></description><content:encoded><![CDATA[【获批】豪森拿下3亿抗肿瘤药！科伦等5家药企紧跟而至]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:02:14 +0800</pubDate></item><item><title>【关注】20亿注射剂！天津药企两个规格首家过评，辉瑞市场再受冲击</title><link>https://mp.weixin.qq.com/s/BlsZ4lZXxRkpfHxDkE09LA</link><description></description><content:encoded><![CDATA[【关注】20亿注射剂！天津药企两个规格首家过评，辉瑞市场再受冲击]]></content:encoded><pubDate>Wed, 02 Jun 2021 19:02:14 +0800</pubDate></item><item><title>儿科中成药市场大缩水，TOP10产品谁最抗压？济川、葫芦娃……新药即将冲刺</title><link>https://mp.weixin.qq.com/s/AMFS2UEUR8Yz5ZfKLp-71g</link><description></description><content:encoded><![CDATA[儿科中成药市场大缩水，TOP10产品谁最抗压？济川、葫芦娃……新药即将冲刺]]></content:encoded><pubDate>Tue, 01 Jun 2021 15:51:53 +0800</pubDate></item><item><title>【米思人物】规模、业态、电商……何煜的“加法”竟是这样（附2021米思会部分拟邀连锁名单）</title><link>https://mp.weixin.qq.com/s/toa5Es4YqyInxdrLifnsMw</link><description></description><content:encoded><![CDATA[【米思人物】规模、业态、电商……何煜的“加法”竟是这样（附2021米思会部分拟邀连锁名单）]]></content:encoded><pubDate>Tue, 01 Jun 2021 15:51:53 +0800</pubDate></item><item><title>【瞩目】普利制药专利挑战成功，拿下畅销抗凝血药ANDA</title><link>https://mp.weixin.qq.com/s/FUbEzxKuGNpuSYRqwTGFsA</link><description></description><content:encoded><![CDATA[【瞩目】普利制药专利挑战成功，拿下畅销抗凝血药ANDA]]></content:encoded><pubDate>Tue, 01 Jun 2021 15:51:53 +0800</pubDate></item><item><title>【焦点】抗肿瘤注射液首家过评，山东药企即将获批</title><link>https://mp.weixin.qq.com/s/Yvgr7T3GdyEg5kNdM1sjhw</link><description></description><content:encoded><![CDATA[【焦点】抗肿瘤注射液首家过评，山东药企即将获批]]></content:encoded><pubDate>Tue, 01 Jun 2021 15:51:53 +0800</pubDate></item><item><title>13个心脑血管独家中成药抢眼！步长、天士力......18个超10亿品牌曝光，这7个大涨</title><link>https://mp.weixin.qq.com/s/sooYh-_DnHBJwNsb4vfDVg</link><description></description><content:encoded><![CDATA[13个心脑血管独家中成药抢眼！步长、天士力......18个超10亿品牌曝光，这7个大涨]]></content:encoded><pubDate>Mon, 31 May 2021 18:30:55 +0800</pubDate></item><item><title>【重磅】实体药店超5000亿市场“四面受敌​”！保健品、中药饮片大有可为</title><link>https://mp.weixin.qq.com/s/Lgvck0xSkDjOo-zOSvL-Vg</link><description></description><content:encoded><![CDATA[【重磅】实体药店超5000亿市场“四面受敌​”！保健品、中药饮片大有可为]]></content:encoded><pubDate>Mon, 31 May 2021 18:30:55 +0800</pubDate></item><item><title>【瞩目】恒瑞将拿下$7亿首仿，超20亿大品种首家过评</title><link>https://mp.weixin.qq.com/s/nyenQ3n-U5dgTJP4rZFE8Q</link><description></description><content:encoded><![CDATA[【瞩目】恒瑞将拿下$7亿首仿，超20亿大品种首家过评]]></content:encoded><pubDate>Mon, 31 May 2021 18:30:55 +0800</pubDate></item><item><title>【聚焦】扬子江药业首个化学药品1类新药磷酸左奥硝唑酯二钠获批上市</title><link>https://mp.weixin.qq.com/s/zRAumvdlGl9GazOYgj6CNA</link><description></description><content:encoded><![CDATA[【聚焦】扬子江药业首个化学药品1类新药磷酸左奥硝唑酯二钠获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 18:30:55 +0800</pubDate></item><item><title>恒瑞、石药、康方……74个新药获批临床！30亿大品种遭冲击，拜耳“广谱”抗癌药来袭</title><link>https://mp.weixin.qq.com/s/LB8dr7-Y-lmGKv5V9zaQ8A</link><description></description><content:encoded><![CDATA[恒瑞、石药、康方……74个新药获批临床！30亿大品种遭冲击，拜耳“广谱”抗癌药来袭]]></content:encoded><pubDate>Sun, 30 May 2021 08:02:52 +0800</pubDate></item><item><title>东曜药业：高风险领域的低风险发展模式</title><link>https://mp.weixin.qq.com/s/EjvYA9dDo6dmudIEAI1vaw</link><description></description><content:encoded><![CDATA[东曜药业：高风险领域的低风险发展模式]]></content:encoded><pubDate>Sat, 29 May 2021 07:57:45 +0800</pubDate></item><item><title>【重磅】药企销售劣药被罚；近300个药退市！汇宇募资19亿仅差一步</title><link>https://mp.weixin.qq.com/s/weGBZCf1vSket2b7dRzaWw</link><description></description><content:encoded><![CDATA[【重磅】药企销售劣药被罚；近300个药退市！汇宇募资19亿仅差一步]]></content:encoded><pubDate>Sat, 29 May 2021 07:57:45 +0800</pubDate></item><item><title>【火热】康恩贝联合万家药店共倡议：“止泻更要消肠炎”</title><link>https://mp.weixin.qq.com/s/hbBI-CMpkB_gpyn1yPslXQ</link><description></description><content:encoded><![CDATA[【火热】康恩贝联合万家药店共倡议：“止泻更要消肠炎”]]></content:encoded><pubDate>Sat, 29 May 2021 07:57:45 +0800</pubDate></item><item><title>10个妇科中成药医院大卖！千金、步长、康缘……9大独家产品亮眼，这两个产品逆势增长</title><link>https://mp.weixin.qq.com/s/r7yk7H_uEG-uSoTCo_yw0Q</link><description></description><content:encoded><![CDATA[10个妇科中成药医院大卖！千金、步长、康缘……9大独家产品亮眼，这两个产品逆势增长]]></content:encoded><pubDate>Fri, 28 May 2021 16:49:42 +0800</pubDate></item><item><title>【获批】恒瑞拿下2亿心血管药首仿后，南京正大天晴也来了</title><link>https://mp.weixin.qq.com/s/vSR1TsxK_6esf8H0Bs0G6Q</link><description></description><content:encoded><![CDATA[【获批】恒瑞拿下2亿心血管药首仿后，南京正大天晴也来了]]></content:encoded><pubDate>Fri, 28 May 2021 16:49:42 +0800</pubDate></item><item><title>【瞩目】浙江药企入局30亿注射剂！阿斯利康失守五成市场</title><link>https://mp.weixin.qq.com/s/GA4H3XXDx93k7IiMDFu61A</link><description></description><content:encoded><![CDATA[【瞩目】浙江药企入局30亿注射剂！阿斯利康失守五成市场]]></content:encoded><pubDate>Fri, 28 May 2021 16:49:42 +0800</pubDate></item><item><title>【关注】5亿抗抑郁药！上海医药拿下首家过评</title><link>https://mp.weixin.qq.com/s/UFl1lsszP6ybqsRd43sQYg</link><description></description><content:encoded><![CDATA[【关注】5亿抗抑郁药！上海医药拿下首家过评]]></content:encoded><pubDate>Fri, 28 May 2021 16:49:42 +0800</pubDate></item></channel></rss>